Drug
Cardiovascular Polypill
Cardiovascular Polypill: highest development phase Phase 3, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cardiovascular Polypill NCT02596126 | Phase 3 | Myocardial Infarction |
Latest
No recent events.
Follow Cardiovascular Polypill on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.